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Summary
 
The tyrosine kinase p56lck regulates the differentiation and proliferative expansion of pre-T
cells. However, nothing is known about other signaling molecules that operate with p56lck to
mediate the pleiotropic changes that occur at this stage of thymocyte development. We used a
genetic strategy to examine the requirement for the GTPase Rho in p56lck-mediated signals in
the thymus. By generating mice double transgenic for a constitutively activated form of p56lck
(p56lck
 
F505
 
) and the Rho inhibitor C3 transferase we were able to compare thymocyte devel-
opment in mice expressing active p56lck on a wild-type or Rho
 
2
 
 background. Thymocytes
expressing active p56lck show enhanced proliferation of pre-T cells resulting in increased num-
bers of late pre-T cells, however, this dramatic effect on pre-T cell proliferation is lost when
the p56lck transgene is expressed in thymocytes lacking endogenous Rho GTPase function.
Expression of active p56lck also generates double positive (DP) thymocytes with low levels of
CD2 antigen expression. Again, p56lck cannot prevent expression of CD2 when expressed on
a Rho
 
2
 
 background. CD4
 
1
 
CD8
 
1
 
 DP cells expressing active p56lck have been shown to lack
functional 
 
a/b
 
–T cell receptor (TCR) complexes due to p56lck-mediated inhibition of TCR
gene V
 
b
 
-D
 
b
 
 rearrangement. This inhibition of TCR expression by active p56lck is unim-
paired in the absence of Rho function. The signaling pathways that are mediated by p56lck and
control thymocyte proliferation, 
 
a/b
 
-TCR and CD2 antigen expression can thus be distin-
guished by their dependency on Rho function.
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L
 
ymphocyte development in the thymus is dependent
on signaling pathways generated by antigen receptors
and cytokine receptors (1, 2). Different developmental
stages within the thymus can be defined by expression of
CD4 and CD8 molecules which act as receptors for MHC
class II and class I molecules, respectively. The earliest T
cell progenitors are found within the CD4
 
2
 
CD8
 
2
 
 double
negative (DN)
 
1
 
 population that comprises 2–3% of the total
thymocyte population. These progenitor cells can be fur-
ther subdivided into four developmental stages on the basis
of expression of CD44 and CD25 molecules: the earliest
progenitors are CD44
 
1
 
CD25
 
2
 
, followed sequentially by
CD44
 
1
 
CD25
 
1
 
, CD44
 
2
 
CD25
 
1
 
, and CD44
 
2
 
CD25
 
2
 
 stages.
At the CD44
 
2
 
CD25
 
1
 
 stage, cells that successfully rearrange
their TCR-
 
b
 
 locus proliferate rapidly, downregulate CD25
and differentiate into CD4
 
1
 
CD8
 
1
 
 double positive (DP)
cells. The process of allelic exclusion arrests further rear-
rangement at the TCR-
 
b
 
 locus and ensures the generation
of DP thymocytes with a single productive TCR-
 
b
 
 chain.
DP cells then undergo TCR-
 
a
 
 chain rearrangements and
upon expression of a functional 
 
a/b
 
-TCR complex are
subjected to the processes of positive and negative selection
that ensures the generation of CD4
 
1
 
CD8
 
2
 
 or CD4
 
2
 
CD8
 
1
 
single positive (SP) thymocytes that exit to the periphery.
The transition of cells from the CD44
 
2
 
CD25
 
1
 
 to the
CD44
 
2
 
CD25
 
2
 
 compartment is a critical checkpoint for
thymocyte differentiation and is controlled by signals gen-
erated by the pre-TCR complex. Mice lacking expression
of any of the components of this complex such as the
CD3
 
e
 
 subunit (3), the TCR-
 
b
 
 chain (4), or the pT
 
a
 
 sub-
unit (5) show a developmental block at the CD44
 
2
 
CD25
 
1
 
stage.
The signal transduction pathways used by the pre-TCR
to control T cell differentiation involve the activation of
 
1
 
Abbreviations used in this paper:
 
 DN, double negative; DP, double positive;
ISP, immature CD8 single positive cells; SP, single positive; TN, triple
negative.
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protein tyrosine kinases. Mouse strains with null mutations
in the tyrosine kinases p56lck (6), ZAP70, and Syk (7), or
their regulatory molecules such as CD45 (8) show defects
at the pre-T cell stage of development. Several other stud-
ies in particular highlight the importance of the tyrosine ki-
nase p56lck in the transmission of pre-TCR–mediated sig-
nals. Mice lacking p56lck or overexpressing a dominant
inhibitory p56lck mutant (6, 9) show a defect in early thy-
mopoiesis similar to that seen in pT
 
a
 
 or TCR-
 
b
 
 chain–defi-
cient mice. Additionally, transgenic expression of a consti-
tutively active form of p56lck can induce the transition of
thymocyte progenitors from the CD44
 
2
 
CD25
 
1
 
 to the
CD44
 
2
 
CD25
 
2
 
 compartment and induce the generation of
DP thymocytes in mice lacking expression of the pre-TCR
complex, e.g., in RAG
 
2
 
/
 
2
 
 or pT
 
a
 
2
 
/
 
2
 
 mice (10, 11). This
indicates that activated p56lck is sufficient to initiate all the
critical events that occur as CD44
 
2
 
CD25
 
1
 
 early pre-T cells
develop into CD44
 
2
 
CD25
 
2
 
 late pre-T cells: the onset of
rapid cell cycle progression, allelic exclusion at the TCR-
 
b
 
chain locus and ultimately expression of CD4 and CD8.
We recently generated mice that lack function of the GTP-
ase Rho in thymocytes due to tissue-specific transgenic ex-
pression of a Rho inhibitor, C3 transferase, which selectively
ADP-ribosylates Rho and thereby abolishes its biological
activity (12). The phenotype of these mice indicated that Rho
might also be important for pre-TCR function (13). Mice
lacking Rho function in the thymus were able to generate
DP and SP thymocytes, but at severely reduced levels. Loss
of Rho function resulted in decreased cell proliferation in
CD44
 
2
 
CD25
 
2
 
 
 
late pre-T cells due to a partial block in G1/S
cell cycle progression. This stage of thymocyte development
is regulated by p56lck which raises questions about the po-
sitioning of Rho in the context of the p56lck signals that
control the proliferation of early thymocyte progenitors. In
fact, very little is known about the signaling pathways down-
stream of p56lck that control pre-T cell differentiation.
Given the involvement of both p56lck and the GTPase Rho
in the regulation of proliferation in late pre-T cells we con-
sidered it possible that Rho might function in the signaling
pathways used by p56lck to regulate the checkpoints for
proliferation and differentiation at the pre-T cells stage of
thymocyte development. To explore these questions, we gen-
erated mice double transgenic for active p56lck (p56lck
 
F505
 
;
reference 14) and C3 transferase (12) and examined the
ability of active p56lck to drive thymocyte proliferation and
differentiation in the absence of Rho function. Mice express-
ing active p56lck show accelerated pre-T cell proliferation
and generate CD4
 
1
 
CD8
 
1
 
 DP thymocytes that fail to express
 
a/b
 
-TCR complexes via a process that mimics allelic exclu-
sion. The present study reveals that the proliferative signals
generated by p56lck are suppressed in mice lacking thymic
Rho function. In contrast the ability of active p56lck to
suppress expression of 
 
a/b
 
-TCR complexes is unimpaired.
p56lck thus uses either qualitatively or quantitatively differ-
ent signals to control thymocyte development at the pre-T
cell stage, p56lck-mediated signaling pathways for prolifer-
ation are dependent on the Rho GTPase whereas signals
for regulation of antigen receptor expression are not.
 
Materials and Methods
 
Transgenic Mice.
 
Transgenic mice expressing the C3 trans-
ferase transgene under the control of the proximal p56lck pro-
moter were generated as previously described (12). Mice trans-
genic for an activated form of the tyrosine kinase p56lck
(p56lck
 
F505
 
; strain pLGF-2964, 10 copies of p56lck
 
F505
 
 transgene)
were provided by Dr. Roger M. Perlmutter (Merck Research
Labs.; 14). Expression of this transgene is also driven by the prox-
imal p56lck promoter, restricting expression of the transgene to
thymocytes. Mice were kept under SPF conditions and bred to
C57BL/6/J mice to maintain the transgenic lines. Mice double
transgenic for C3 transferase and p56lck
 
F505
 
 (pLGF/C3) were
generated by cross-breeding of the parental strains.
 
PCR.
 
Offspring were genotyped for the presence of both
transgenes by PCR analysis of genomic mouse DNA using trans-
gene specific primer pairs: b-actin (actin 1: 5
 
9
 
-GTGGCCATCTC-
CTGCTCGAAGTC-3
 
9 
 
and actin 2: 5
 
9
 
-GTTTGAGACCTTCA-
ACACCCC-3
 
9
 
); C3 transferase (G9112: 5
 
9
 
-GCCACCATG-
GAGCAGAAGCTGATCTCCG-3
 
9 
 
and C3NT: 5
 
9
 
-CTGATT-
TGCTTAGTCCATAC-3
 
9
 
), and p56lckF505 (pLGF-Fwd: 5
 
9
 
-
ATGACTTCTTCACAGCCACAGAGGG-3
 
9 
 
and pLGF-Rev:
5
 
9
 
-TTTTATTAGGACAAGGCTGGTGGGC-3
 
9
 
).
PCR reactions were performed in 20 mM ammonium sul-
phate, 75 mM Tris-HCl, pH 9.0, 0.01% Tween 20, 1.2 mM
MgCl
 
2
 
, 200 
 
m
 
M dNTP, 0.5 U Taq DNA polymerase, and 1 
 
m
 
M
of each primer. Genomic DNA was purified from mouse ear clips
and used as template for 30 cycles of polymerase chain reaction
(57
 
8
 
C annealing, 72
 
8
 
C elongation, 95
 
8
 
C denaturation). PCR
products were separated in 2% agarose gels and stained with
ethidium bromide.
 
Thymocyte Preparation.
 
Young adult mice of 
 
z
 
4–6 wk of age
were typically analyzed. Thymocytes were obtained by carefully
mincing the thymus with forceps and filtering through a fine
mesh filter to obtain a single cell suspension. Total cell numbers
were determined by counting of trypan blue stained thymocytes
within a representative volume of cell suspension using a Neu-
bauer hemocytometer.
 
Flow Cytometric Analysis.
 
Freshly isolated thymocytes were
stained with saturating concentrations of antibody in 100 
 
m
 
l cold
PBS supplemented with 1% BSA on ice for 30 min in a 96-well
V-bottom shaped microtiter plate. Cells were washed twice in
between incubations with this buffer. In a first step cells were in-
cubated with anti-FcgRII mAb in order to block any unspecific
staining. All mAb used were conjugated to either FITC, PE, or
biotin. Biotinylated mAb were revealed using streptavidin-Tri-
color (Caltag
 
 
 
Laboratories, South San Francisco, CA). The fol-
lowing mAb were used (all PharMingen, San Diego, CA): CD8
(53-5.8), CD4 (RM4-5), CD25 (IL2R 
 
a
 
 chain, 3C7), CD3
 
e
 
(145-2C11), 
 
a/b
 
-TCR (
 
b
 
 chain, H57-597), B220 (CD45R,
RA3-6B2), CD44 (Pgp-1, IM7), CD2 (LFA-2, RM2-5), Mac-1
(
 
a
 
 chain, M1/70), Gr-1 9 (Ly-6G, RB6-8C5), and NK (2B4,
129/J). Cells stained negative for CD4, CD8, CD3, B220, Gr-1,
Mac-1, and the NK-cell marker 2B4 were labeled Lin
 
2
 
. Stained
thymocytes were analyzed on a FACS
 
Ò
 
 Calibur (Becton Dickin-
son & Co., Sparks, MD) using CellQuest software (Becton Dick-
inson & Co.). Viable cells were gated on the basis of forward and
side light scatter.
 
Cell Cycle Analysis.
 
Cellular DNA content was assayed by
standard techniques using staining with propidium iodide. In
brief, thymocytes were stained with biotinylated mAb against
CD4, CD8, CD3, B220, NK, Mac-1, Gr-1, and CD44 and sur-
face staining revealed with FITC conjugated Avidin (Sigma
Chemical Co., St. Louis, MO). Cells were fixed in 70% ethanol 
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for 30 min on ice, washed free of ethanol, RNase (1 mg/ml)
treated for 15 min at room temperature, and then resuspended in
propidium iodide (50 ug/ml in PBS) in order to stain DNA.
Maintaining a low flow rate events were collected and propidium
iodide fluorescence was measured 
 
.
 
600 nm on a FACS
 
Ò
 
Calibur
(Becton Dickinson & Co.). DNA content of FITC-negative
(CD44
 
2
 
Lin
 
2
 
) thymocytes was analyzed using a doublet discrimi-
nation module.
 
Results
 
Loss of Endogenous Rho Function Inhibits p56lck-mediated
Proliferative Responses and Developmental Maturation in Pre-T
Cells.
 
The developmental maturation of pre-T cells is as-
sociated with downregulation of the CD25 surface marker
and the acquisition of CD4 and CD8 molecules (15). At
this stage, only thymocytes that productively rearranged
their TCR-
 
b
 
 chain and express a complete pre-TCR com-
plex are selected for further development and transition into
the DP compartment, a process known as 
 
b
 
-selection (16,
17). Current models propose that the pre-TCR complex
triggers this maturation program via intracellular signaling
pathways that involve activation of the tyrosine kinase
p56lck (18). 
 
b
 
-selection is bypassed in thymocytes that ex-
press a constitutive activated form of p56lck (19), resulting
in differentiation and proliferation of all CD44
 
2
 
CD25
 
1
 
pre-T cells, regardless of a productive or unproductive 
 
b
 
chain rearrangement. Accordingly, pLGF mice expressing a
constitutively active p56lck (p56lckF505) transgene in the
thymus show enhanced generation of CD442CD252 pre-T
cells compared with normal control mice (10). Comparison
of CD25 expression on CD442 triple negative (TN) thy-
mocytes (CD442CD42CD82CD32) from pLGF mice with
normal control mice shows how expression of activated
p56lck results in an increased frequency of CD442CD252
late pre-T cells and a concomitant low frequency of
CD442CD251 early pre-T cells (Fig. 1 a).
Analysis of the cellular DNA content of pre-T cells from
pLGF mice compared with normal control mice is shown
in Fig. 1 b. We observed a marked increase of cells in the
proliferative S and G2 phases of the cell cycle in CD442 TN
thymocytes from pLGF mice when compared with cells of
the same phenotype from normal control mice. Thy-
mocyte-specific transgenic expression of activated p56lck
thus accelerates proliferative responses in pre-T cells. The
dramatic enhancement of the production of late pre-T cells
by active p56lck is illustrated by a comparison of total cell
numbers for this population in pLGF mice compared with
control mice. A normal thymus contains an average num-
ber of CD252CD442 late pre-T cells of 1.2 3 106, whereas
in pLGF mice their numbers are typically increased to
z6.0  3 106. There is thus a fivefold increase in total num-
bers of CD442CD252 late pre-T cells in thymi from pLGF
mice compared with thymi from normal control mice.
Proliferative responses in late pre-T cells are reduced in
thymi lacking endogenous Rho function as a consequence
of transgenic expression of C3 transferase (C3). These cells
show a severe decrease in the production of late pre-T cells
(12). To explore whether p56lck-mediated responses in
early T cell development required endogenous Rho function
we crossed pLGF mice (14) to transgenic mice with inacti-
vated thymic Rho function (C3). We then used CD44 and
CD25 markers to analyze early thymocyte progenitors in
TN thymocytes of pLGF/C3 double transgenic mice. To-
tal cell numbers and the cell cycle status of the CD442252
pre-T cell compartment were monitored. The data in Fig.
2 a show that the increases in the percentage of cycling
pre-T cells seen in pLGF mice are lost in pLGF/C3 double
transgenic mice, i.e., loss of Rho function antagonizes the
action of p56lck in driving cell cycle progression in pre-T
cells. There are still some cycling cells in pre-T cells from
pLGF/C3 double transgenic mice but the loss of Rho
Figure 1. Transgenic expression of activated p56lck enhances differen-
tiation and proliferation of pre-T cells. (A) CD25 expression profiles of
CD44neg TN thymocytes in normal control mice and pLGF transgenic
mice expressing active p56lck. Single cell suspensions of total thymocytes
from normal control and pLGF transgenic mice were prepared and
stained with mAb against a panel of mature lineage markers including
CD4, CD8, CD3, B220, NK, Gr-1, Mac-1 (all biotinylated), CD44 (bio-
tinylated), and CD25 (FITC). Cells negative for all lineage markers and
CD44 were gated and examined for their CD25 expression profile. (B)
Transgenic expression of active p56lck leads to increased levels of
CD44neg  TN thymocytes in S1G2/M phase of the cell cycle. Total thymo-
cytes from normal and pLGF transgenic mice were prepared and stained
with mAb against CD44 (biotinylated) and a panel of mature lineage
markers including CD4, CD8, CD3, B220, NK, Gr-1, and Mac-1 (all
biotinylated), fixed in 70% ethanol, and stained with propidium iodide
(PI). Cells lacking expression of CD44 and all lineage markers were gated
and then examined for their DNA profile.934 Role of Rho in p56lck-mediated Responses in Pre-T Cell Development
function appears to prevent the ability of activated p56lck
to induce a hyperproliferative response in CD442CD252
late pre-T cells.
The most striking consequence of the decreased prolifer-
ative capacity of pre-T cells in pLGF/C3 double transgenic
mice is presented in Fig. 2 b, which shows absolute num-
bers of CD442CD252 late pre-T cells in pLGF and pLGF/C3
mice. The data reveal that in the absence of endogenous
Rho function p56lck is unable to enhance the production
of CD442CD252 late pre-T cells. Thus, pLGF/C3 double
transgenic mice do not show the skewed distribution of
CD442CD252 and CD442CD251 subpopulations seen in
pLGF mice. These results indicate that Rho function is re-
quired for active p56lck to accelerate the transition of early
thymocytes from the CD442CD251 to the CD442CD252
compartment.
p56lck-mediated Inhibition of a/b-TCR Expression and
Generation of CD41 or CD81 SP Thymocytes Is Not Rho De-
pendent. The consequence of a productive rearrangement
of the TCR-b locus in thymocytes is expression of the pre-
TCR complex and the initiation of the process of allelic
exclusion that ensures that mature T cells express a TCR
complex with only one b chain (20). p56lck function is re-
quired for this pre-TCR initiated response. Moreover,
transgenic expression of activated p56lck inhibits V-DJ b-rear-
rangements  and expression of the TCR-b chain in thy-
mocytes. Consequently, DP thymocytes that develop in
pLGF mice show defective expression of the TCR–CD3
complex (19). The data in the left panel of Fig. 3 a show a/b-
TCR staining profiles of thymocytes from pLGF mice in
comparison with thymocytes from control littermate mice.
Normal thymocytes contain a large subpopulation of cells
expressing intermediate levels of the TCR–CD3 complex
and a smaller subset of cells with upregulated, higher levels
of TCR expression. In contrast, thymocytes derived from
pLGF mice show an abnormal a/b-TCR staining pattern
with few intermediate or high a/b-TCR positive cells.
If Rho function was required for p56lck-mediated sup-
pression of TCR-b chain rearrangements then expression
of activated p56lck in Rho2 thymocytes would not pre-
vent expression of the a/b-TCR complex. Thymocytes
from pLGF/C3 double transgenic mice should then express
a mature a/b-TCR complex, undergo positive selection,
and generate mature SP thymocytes in the normal ratio.
Conversely, if Rho function was not required for p56lck-
mediated regulation of a/b-TCR expression then pLGF/
C3 thymocytes should show a pattern of TCR expression
and CD4/CD8 differentiation like that seen in pLGF thy-
mocytes that express active p56lck alone. Therefore, we
analyzed expression of the TCR–CD3 complex and the
development of CD4 and CD8 mature SP cells in thy-
mocytes from pLGF/C3 double transgenic mice. As shown
in the right panel of Fig. 3 a, pLGF/C3 thymocytes that
express active p56lck on a Rho2 background fail to nor-
mally express a mature TCR–CD3 antigen receptor com-
plex.
The absence of a mature TCR–CD3 complex interrupts
the normal processes of positive and negative selection and
inhibits CD4 and CD8 SP development in the thymus of
pLGF mice. As shown in the upper right panel of Fig. 3 b,
thymocytes expressing active p56lck comprise CD42CD82
DN and CD41CD81DP cells but abnormally low levels of
CD41 or CD81 SP cells. We have shown previously that
positive and negative selection processes of DP thymocytes
occur undisturbed in the absence of Rho function (12).
Adult thymi which lack endogenous Rho function show
severe hypocellularity of only z5–10% of normal cell
numbers but do contain DP and mature SP thymocytes
with normal expression levels of the TCR–CD3 complex
(Fig. 3 b, lower left). The lower right panel in Fig. 3 b shows
the result of a representative analysis of CD4/CD8 subpop-
ulations in pLGF/C3 thymocytes. The frequencies of DP
and mature SP cells of thymocytes from pLGF/C3 double
transgenic mice are identical to that of thymocytes from
pLGF mice. The data in Fig. 3 thus show that introduction
of an activated p56lck transgene into thymocytes lacking
endogenous Rho function prevents the expression of the
a/b-TCR complex and consequently, because positive se-
Figure 2. Inactivation of Rho function inhib-
its p56lck-initiated pre-T cell proliferation. (A)
Inactivation of Rho function during early thy-
mopoiesis prevents hyperproliferative responses
in pre-T cells from pLGF transgenic mice. Flow
cytometric analysis of cellular DNA content of
CD44neg TN thymocytes from pLGF transgenic,
and pLGF/C3 double transgenic mice as de-
scribed above. (B) Loss of Rho function pre-
vents the accumulation of CD252CD442 pre-T
cells in thymocytes expressing active p56lck.
Total thymocytes from normal, pLGF transgenic
and pLGF/C3 double transgenic mice were pre-
pared and stained with mAb against a panel of
mature lineage markers including CD4, CD8,
CD3, B220, NK, Gr-1, Mac-1 (all biotinylated),
CD25 (FITC), and CD44 (PE). Thymocytes
negative for all lineage markers were gated and
examined for their CD25/CD44 profiles. Absolute cell numbers in individual CD25/CD44 thymocyte subsets were calculated on the basis of average per-
centages obtained in these analyses and average numbers of TN thymocytes in pLGF and pLGF/C3 mice. Columns represent means of six mice analyzed,
bars indicate standard deviations.935 Henning and Cantrell
lection can not occur, the generation of mature CD4 and
CD8 SP thymocytes. In this context, the outcome of ex-
pression of activated p56lck in terms of inhibition of a/b-
TCR complexes and suppression of the differentiation of
CD4 and CD8 SP cells is the same in Rho2 and normal
thymocytes.
Immature CD8 single positive cells (ISP), distinguished by
low levels of CD8 antigen expression but no expression of the
TCR–CD3 complex, represent an intermediate stage in the
transition from the CD42CD82 DN to the CD41CD81
DP compartment (21, 22). These cells are not easy to dis-
cern in normal thymocytes but can accumulate in mice
where there is a partial block or a delay in the DN to DP
transition. For example, an accumulation of CD8lowCD32
ISPs was seen in mice lacking expression of the transcrip-
tion factors Tcf-1 and Lef-1 (23). A consistent and repro-
ducible observation was that thymocytes from pLGF/C3
double transgenic mice contained higher frequencies of
CD8 low ISPs when compared with pLGF single transgenic
mice (Fig. 3 c).
Activated p56lck Regulates Expression of CD2 by a Rho-
dependent Pathway. In normal thymocyte development
pre-TCR–mediated downregulation of CD25 expression is
accompanied by upregulation of the expression of the CD2
antigen (24, 25). The data in Fig. 4 a show CD2 expression
of thymocytes isolated from a normal young C57/BL6
mouse. CD2 expression is found on CD41CD81 DP and
SP thymocyte populations. There is a subtle but clear regu-
lation of CD2 expression levels during normal thymocyte
development in that SP thymocytes express about threefold
higher levels of the CD2 antigen than DP thymocytes.
Fig. 4 b shows a comparison of CD2 antigen expression
on thymocytes from normal mice, pLGF transgenic and
pLGF/C3 double transgenic mice. The representative pro-
files depicted here show that expression of active p56lck re-
sults in an about fourfold reduction in CD2 antigen expres-
sion levels compared with normal control thymocytes.
Expression profiles of other T cell markers such as Thy-1.2
are normal in pLGF thymocytes (Fig. 4 b, lower panel). Sim-
ilarly, levels of CD4 and CD8 on DP thymocytes from
pLGF thymocytes are comparable to levels seen in normal
control mice (Fig. 3 b). Expression of active p56lck thus se-
lectively downregulates expression of CD2 antigen. In
contrast, loss of Rho function during thymocyte develop-
ment does not alter CD2 expression levels in adult thy-
mocytes (13). To explore whether the downregulation of
CD2 expression in pLGF thymocytes was a Rho depen-
dent phenomenon we analyzed CD2 antigen levels on thy-
mocytes from LGF/C3 double transgenic mice (Fig. 4 b,
upper right panel). These experiments reveal normal levels of
CD2 antigens on pLGF/C3 thymocytes. Thus, transgenic
Figure 3. Failed expression of a/b-TCR complexes and development
of mature SP cells in thymocytes expressing active p56lck is independent
of endogenous Rho function. (A) a/b-TCR expression in normal and
Rho2 thymocytes expressing active p56lck. Total thymocytes from nor-
mal control mice, pLGF transgenic and pLGF/C3 double transgenic mice
were stained for a/b-TCR expression (anti–TCR-b chain-FITC) and
TCR expression profiles of transgenic mice (shaded) were compared with
normal profiles (outline) by overlay. (B) Expression of CD4 and CD8
markers in normal and Rho2 thymocytes expressing active p56lck. Rep-
resentative dual parameter histograms for CD4 and CD8 expression of to-
tal thymocytes isolated from adult normal, C3 and pLGF transgenic and
pLGF/C3 double transgenic mice. Percentages of individual CD4/CD8
subpopulations are indicated. Data shown are representative of four such
experiments. (C) Frequencies of CD42CD8low cells in normal and Rho2
thymocytes expressing active p56lck. Three representative dual parameter
histograms for CD4 and CD8 expression of total thymocytes isolated
from adult pLGF transgenic and pLGF/C3 double transgenic mice are
shown. Percentages of CD42CD8low subpopulations are indicated.936 Role of Rho in p56lck-mediated Responses in Pre-T Cell Development
expression of active p56lck in the thymus interferes with
the generation of normal levels of CD2. However, induced
reduction of CD2 antigens occurs only in normal thy-
mocytes but not in thymocytes lacking endogenous Rho
function, p56lck downregulation of CD2 is thus a Rho-
dependent response.
Discussion
The differentiation and proliferative expansion of pre-T
cells is mediated via signaling pathways which involve activa-
tion of the tyrosine kinase p56lck (10, 11). However, noth-
ing is known about other signaling molecules that operate
with p56lck to mediate the complex molecular changes that
occur at this stage of thymocyte development. To examine
the role of the GTPase Rho in p56lck-mediated signals in
the thymus, we generated mice double transgenic for active
p56lck and the Rho inhibitor C3 transferase. This enabled us
to compare thymocyte development in mice expressing
active p56lck on a wild-type or Rho2 background.
Mice with thymocyte-specific expression of a transgene
encoding active p56lck show strong potentiation of prolif-
erative responses in pre-T cells that results in a fivefold in-
crease in numbers of CD442CD252 late pre-T cells. This
p56lck-mediated response is abrogated when the active
p56lck transgene is expressed in thymocytes which lack en-
dogenous Rho function. Rho function is thus required for
p56lck to drive the differentiation of pre-T cells from the
CD442CD251 into the CD442CD252 compartment and
to accelerate proliferative responses in this population. It
has been shown that expression of active p56lck inhibits
TCR-b chain rearrangements; DP thymocytes that de-
velop in pLGF thymocytes fail to normally express a/b-
TCR complexes (19). We now show that active p56lck
can prevent expression of a/b-TCR complexes on DP
thymocytes in the absence of endogenous Rho function.
Interestingly, active p56lck also generates DP thymocytes
that express downregulated levels of CD2 antigens when
compared with normal thymocytes. However, our data
show that p56lck does not prevent expression of CD2
Figure 4. Thymocytes that express ac-
tive p56lck show downregulation of CD2
antigen expression via a Rho dependent
mechanism. (A) CD2 antigen expression in
TN, DP, and SP subsets of normal mouse
thymocytes. Normal thymocytes from C57/
BL6 mice were stained for expression of
CD2 (PE), CD4 (FITC), and CD8 (bio-
tinylated) or CD4, CD8, CD3 (all FITC),
and CD2 (PE) and analyzed by flow cytom-
etry. CD42CD82CD32 TN, CD41CD81
DP and CD41 SP cells were gated and ex-
amined for CD2 expression. Mean fluores-
cence intensity for CD2 expression was 350
for DP thymocytes and 1,150 for SP thy-
mocytes. (B) Expression of active p56lck re-
sults in downregulation of CD2 expression
in normal thymocytes but not in thy-
mocytes lacking endogenous Rho func-
tion.  Total thymocytes from normal control
mice, pLGF transgenic and pLGF/C3 dou-
ble transgenic mice were stained for expres-
sion of CD2 (PE) and Thy1.2 (FITC) and
analyzed by flow cytometry. Mean fluores-
cence intensity for CD2 expression in DP
thymocytes from the individual mice were:
291 for controls, 108 for pLGF, and 275 for
pLGF/C3.937 Henning and Cantrell
when expressed on a Rho2 background. p56lck thus regu-
lates thymocyte development at the pre-T cell stage by
both Rho-dependent and Rho-independent responses.
It has been suggested that one critical role for p56lck at
the pre-T cell stage of thymocyte development is to medi-
ate allelic exclusion at the TCR-b chain locus (19, 26, 27).
Expression of a constitutive active form of p56lck can ini-
tiate thymocyte differentiation in RAG2/2 or pTa2/2
mice (10, 11) and switch off rearrangements at the TCR-b
locus. Further evidence for the role of p56lck in preventing
rearrangement at the TCR-b locus stems from observa-
tions that DP thymocytes that develop in the presence of
active p56lck fail to express TCR-b subunits. They do not
show rearrangements at the TCR-b locus, do not express a
functional a/b-TCR complex and fail to develop into ma-
ture CD41 or CD81 SP thymocytes (19, 26).
The current model to explain this phenomenon is that
p56lck acts as a sensor for the expression of a functional
pre-TCR complex. Successful expression of a functional
pre-TCR complex would normally activate p56lck and
initiate the feedback mechanism that prevents further rear-
rangements of TCR-b chains, i.e., p56lck mediates allelic
exclusion at the pre-T cell stage. The failure of TCR-b
chain rearrangements in cells expressing active p56lck is
thus thought to reflect the fact that such cells initiate the al-
lelic exclusion mechanism before they have produced a
competent TCR-b subunit. Once such cells differentiate
into DP thymocytes there is no TCR-b chain to partner
newly synthesized TCR-a subunits and consequently ex-
pression of a mature TCR–CD3 antigen receptor complex
does not occur. This results in failed positive and negative
selection and impaired development of mature SP thy-
mocytes. The present data show that loss of Rho function
has no influence on the ability of active p56lck to prevent
expression of a/b-TCR complexes. Since the failure to ex-
press a/b-TCR complexes in thymocytes expressing active
p56lck is a model for allelic exclusion, the simplest inter-
pretation of the present data is that Rho function is not re-
quired for allelic exclusion at the TCR-b locus.
In this study, we demonstrate that expression of active
p56lck in thymocytes not only prevents expression of ma-
ture a/b-TCR complexes but also regulates expression of the
accessory molecule CD2. The downregulation of CD25
expression on pre-T cells is normally accompanied by up-
regulation of the expression of the CD2 antigen (24, 25).
Active p56lck can push the differentiation processes that
downregulates expression of CD25, but the resultant cells
do not express normal levels of CD2. The negative regula-
tory effect of active p56lck on CD2 expression can be re-
versed by a concomitant loss of Rho function. This was a
particularly striking result because loss of Rho function did
not restore expression of the a/b-TCR complex on pLGF
thymocytes. The ability of active p56lck to prevent CD2
antigen expression on DP thymocytes is thus dependent on
Rho function whereas the ability of p56lck to inhibit ex-
pression of the a/b-TCR complex is not.
In pLGF/C3 double transgenic mice we observed a con-
sistent increase in frequencies of CD42CD8low cells when
compared with pLGF single transgenic mice. These ISP
represent an intermediate stage in the transition from the
DN to the DP compartment (21, 22). This result suggests
that the transition of late pre-T cells into DP cells is par-
tially suppressed in thymocytes lacking endogenous Rho
function. However, loss of Rho function does not com-
pletely suppress pre-T cell differentiation. Moreover, al-
though it strikingly decreases proliferative responses, it does
not completely abrogate proliferation in late pre-T cells.
The present results thus demonstrate that Rho is a regulator
of pre-T cell development but they equally illustrate that
compensatory, Rho-independent proliferative and differ-
entiation signals must operate in early thymic progenitors.
There is increasing awareness that pre-T cell differentiation
is controlled by overlapping and compensatory signaling
pathways. For example, the tyrosine kinases ZAP70 and
Syk have overlapping and compensatory roles in pre-T
cells (7) as do the transcription factors Tcf and Lef (23).
The present data show that Rho has an important function
in p56lck-mediated signals for thymocyte development.
The fact that pre-T cell differentiation is not absolutely de-
pendent on Rho function is consistent with the fact that
the thymic developmental block in mice deficient for
p56lck is not absolute. In p56lck-deficient mice, the related
kinase p59fyn can partially compensate for p56lck-medi-
ated signals. Thymocytes that are deficient for both p56lck
and p59fyn show a complete block in thymocyte develop-
ment at the pre-T cell stage analogous to the developmen-
tal block seen in RAG2/2 thymocytes (28). Therefore, one
Figure 5. Possible models for the positioning of Rho in p56lck-medi-
ated signaling pathways regulating various aspects of pre-T cell develop-
ment. (A) The pre-TCR initiates signaling pathways mediated by p56lck
that regulate thymocyte development and control the process of allelic
exclusion of the TCR-b locus in pre-T cells. A possible model consistent
with our data locates Rho either directly downstream of p56lck or in par-
allel signaling pathways controlling proliferation and regulation of CD2
expression in pre-T cells. Other signals emerging from p56lck-regulating
inhibition of TCR-b chain rearrangement are Rho independent. Dashed
arrows symbolize as yet formally unproven links between the pre-TCR,
p56lck and Rho. (B) An alternative model compatible with our results
depicts Rho as a signal amplifier which increases the signal intensity gen-
erated by p56lck. Individual biological responses regulated by the pre-
TCR would be dependent on different signal intensities and would only
be initiated if the signaling strength generated by p56lck and Rho would
reach their individual thresholds. Thus, signal intensity in the absence of
Rho function would still be sufficient to mediate inhibition of TCR-b
chain rearrangement but not to downregulate CD2 expression or drive
pre-T cell proliferation.938 Role of Rho in p56lck-mediated Responses in Pre-T Cell Development
speculation is that loss of Rho function causes defects in
p56lck-mediated function in pre-T cells but does not im-
pact compensatory p59fyn signaling pathways. In this re-
spect, the strategy used in this study to inactivate Rho
function is extremely selective. C3 transferase has no inhib-
itory effects on the function of other Rho family GTPases
such as Rac-1, Rac-2, or Cdc42 (29). It will be intriguing
to know if loss of Rho function in the thymus can be com-
pensated by the actions of these other Rho family GTPases.
In summary, the tyrosine kinase p56lck regulates pre-T
cell proliferation and differentiation and controls expression
of  a/b-TCR complexes and CD2 antigens. This study
shows that these p56lck-mediated responses can be distin-
guished by their requirement for Rho function. This re-
quirement of Rho function for p56lck-mediated regulation
of pre-T cell development is consistent with a model
where Rho is part of signaling pathways that emerge from
p56lck and regulate cell cycle progression and CD2 expres-
sion at this developmental stage. The signaling pathways
emerging from p56lck that prevent expression of a/b-
TCR complexes by suppressing TCR gene rearrangement
at the b-locus are apparently independent of the function
of Rho. One interpretation of these results is that qualita-
tively different signaling pathways, some involving Rho
and some not, are being used to control these different
p56lck responses (Fig. 5 a). However, an alternative possi-
bility is that Rho is regulating p56lck-signaling responses
quantitatively. In this model, the same p56lck-induced sig-
naling pathways controls thymocyte proliferation, a/b-
TCR and CD2 expression but these responses require
quantitatively different signaling thresholds (Fig. 5 b). Rho
could thus regulate the strength of p56lck-induced signals.
This model predicts that regulation of TCR-b chain rear-
rangements has a low signaling threshold compared with
the thresholds required for proliferation and control of
CD2 antigen expression. Future studies will determine
whether Rho is positioned directly downstream of p56lck
at the pre-T cell stage or whether Rho is part of a parallel
signaling pathway required for pre-T cell development.
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